We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

133 hedge funds and large institutions have $2.58B invested in Adaptive Biotechnologies in 2019 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 44 increasing their positions, 29 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 22

52% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 29

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

14% more funds holding

Funds holding: 117 → 133 (+16)

4.13% more ownership

Funds ownership: 65.29% → 69.42% (+4.1%)

3% more capital invested

Capital invested by funds: $2.5B → $2.58B (+$87.1M)

68% less call options, than puts

Call options by funds: $1.61M | Put options by funds: $4.99M

Holders
133
Holders Change
+16
Holders Change %
+13.68%
% of All Funds
2.62%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.1%
New
43
Increased
44
Reduced
29
Closed
22
Calls
$1.61M
Puts
$4.99M
Net Calls
-$3.38M
Net Calls Change
-$5.14M

Top Buyers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$42.9M
2
BlackRock
BlackRock
New York
+$36.2M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
+$15.4M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$12.2M
5
TCM
TimesSquare Capital Management
New York
+$11.2M

Top Sellers

Rank Fund Capital Flow
1
FAM
Fred Alger Management
New York
-$30.7M
2
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$13.9M
3
JP Morgan Chase
JP Morgan Chase
New York
-$11.8M
4
LCM
Laurion Capital Management
New York
-$5.47M
5
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$5.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
76
D.E. Shaw & Co
New York
$821K +$788K +27,456 New
ProShare Advisors
77
ProShare Advisors
Maryland
$804K +$772K +26,888 New
TD Asset Management
78
TD Asset Management
Ontario, Canada
$803K +$48.8K +1,700 +7%
LPL Financial
79
LPL Financial
California
$796K +$764K +26,603 New
AllianceBernstein
80
AllianceBernstein
Tennessee
$781K +$341K +11,890 +84%
Deutsche Bank
81
Deutsche Bank
Germany
$637K +$395K +13,750 +180%
AC
82
Athanor Capital
New York
$610K -$71.8K -2,500 -11%
Mitsubishi UFJ Asset Management
83
Mitsubishi UFJ Asset Management
Japan
$539K +$520K +18,100 New
Norges Bank
84
Norges Bank
Norway
$487K -$825K -28,731 -64%
RhumbLine Advisers
85
RhumbLine Advisers
Massachusetts
$469K +$123K +4,291 +38%
DADC
86
D.A. Davidson & Co
Montana
$397K +$381K +13,270 New
WCM
87
Weld Capital Management
New York
$376K +$361K +12,564 New
CIBC Private Wealth Group
88
CIBC Private Wealth Group
Georgia
$344K +$33K +1,150 +11%
GPGA
89
Grandeur Peak Global Advisors
Utah
$323K – – –
OC
90
Oppenheimer & Co
New York
$313K +$301K +10,468 New
UBS Group
91
UBS Group
Switzerland
$297K -$63.5K -2,211 -18%
Coatue Management
92
Coatue Management
New York
$275K +$264K +9,196 New
BFM
93
Boothbay Fund Management
New York
$269K +$258K +9,000 New
Ensign Peak Advisors
94
Ensign Peak Advisors
Utah
$252K +$243K +8,448 New
VWM
95
Vigilare Wealth Management
Arizona
$231K +$221K +7,700 New
CG
96
Caprock Group
Idaho
$226K +$1.09K +38 +0.5%
SEC
97
Seven Eight Capital
New York
$209K +$201K +7,000 New
MML Investors Services
98
MML Investors Services
Massachusetts
$202K +$194K +6,742 New
SG Americas Securities
99
SG Americas Securities
New York
$195K +$187K +6,520 New
Ohio Public Employees Retirement System (OPERS)
100
Ohio Public Employees Retirement System (OPERS)
Ohio
$168K -$5.54K -193 -3%
2 3
4
5 6

ADPT Hedge Fund Activity: Q4 2019 in Review

133 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q4 2019, worth a combined $2.58B — up 3.5% from $2.5B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new ADPT positions and 22 closed out — a net gain of 21 holders — while 44 added to existing stakes and 29 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $42.9M. The largest seller was Fred Alger Management, cutting an estimated $30.7M.

  • 133 institutional investors held Adaptive Biotechnologies (ADPT) as of Q4 2019, up from 117 in Q3 2019.
  • Funds reported $2.58B of Adaptive Biotechnologies stock for Q4 2019, up 3.5% quarter-over-quarter.
  • 43 funds opened new Adaptive Biotechnologies positions in Q4 2019 and 22 closed out, a net change of +21 holders.
  • The largest Adaptive Biotechnologies buyer in Q4 2019 was T. Rowe Price Associates, an estimated $42.9M added.
  • The largest Adaptive Biotechnologies seller in Q4 2019 was Fred Alger Management, an estimated $30.7M sold.

Based on aggregated 13F filings for Q4 2019.